About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

SHANGHAI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, was recognized as an “Outstanding Growth Story in Hong Kong Stocks” at the China Capital Market Development Forum, held in Shanghai from September 16–17 and hosted by ChinaFund.

The award highlights Hong Kong-listed companies with exceptional performance in technology innovation, earnings growth and industry influence, and reflects confidence in Fangzhou’s solid operations and continued innovation.

A red poster for the 2025 China Listed Company Yinghua Award. It shows that fangzhou won the "Hong Kong Stock Growth Demonstration Case

Fangzhou Named ‘Outstanding Growth Case in Hong Kong Stocks’

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, remarked: “Winning this award affirms our strength in innovation and growth, but more importantly, it signals strong recognition of the value that AI can bring to chronic disease management.”

In its 2025 interim results, Fangzhou reported revenue of RMB 1.5 billion, up 12.9% year-on-year. Net profit reached RMB 12.5 million, reaching profitability for the period, while adjusted net profit climbed 16.8% to RMB 17.6 million, a record high. The platform’s registered user base expanded 15.8% to 52.8 million, with 11.9 million monthly active users, up 34.4% year-on-year. Registered doctors reached 229,000, while paid user repurchase rate stood at 85.4%. Its drug catalog SKU grew to 216,000, backed by partnerships with over 1,650 suppliers and 980 pharmaceutical firms.

Earlier this month, at its 10th H2H Healthcare Ecosystem Conference in Shanghai, Fangzhou released its proprietary “XingShi” Large Language Model (“XS LLM”), an AI system engineered to address critical inefficiencies in chronic disease management by improving service efficiency, delivering improved personalization, and helping to make better use of physicians’ available time.

XS LLM integrates multimodal capabilities — image and speech recognition, natural language processing, large-scale medical knowledge storage, and reasoning — while achieving advanced performance benchmarks in medical AI. This core system supports five domain-specific intelligent agents: “AI Knowledge Agent”, “AI Guidance Agent”, “AI Pre-Consult Agent”, “AI Doctor Assistant”, and “AI-Electronic Medical Record (EMR) Agent”. Together, these agents create a closed-loop service architecture spanning the full lifecycle of chronic disease management.

Built as the “core digital brain” of Fangzhou’s platform, the model currently powers five AI-enabled applications: AI Medication Finder, AI Health Manager, AI Doctor Assistant, AI Academic Assistant, and AI-Powered Search.

During the conference, Fangzhou also announced strategic partnerships with Innovent Biologics and Zhejiang Otsuka Pharmaceutical to jointly advance digital health management. Fangzhou will leverage its strengths in AI technology and platform operations to build new digital health collaboration models with partners, injecting fresh momentum into the “Healthy China 2030” initiative.

About China Capital Market Development Forum
Hosted by ChinaFund, the forum brought together nearly 1,000 representatives from regulators, industry, and investment to discuss new paths and opportunities for China’s capital markets.

About Fangzhou Inc.
Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform, serving 52.8 million registered users and 229,000 physicians (as of June 30, 2025). The Company specializes in delivering tailored medical care and AI-enabled precision medicine solutions. For more information, visit https://investors.jianke.com.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3d900a82-84c9-49b0-b9f4-b182491e2929


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.